Reviva Pharmaceuticals Priced An Underwritten Offering Of 4.76M Shares (Or Pre-funded Warrants In Lieu Thereof) And Investor Warrants To Purchase Up To 4.76M Shares, Combined Price Of Each Share And Accompanying Warrant Is $1.05 And Each Pre-funded...
Reviva Pharmaceuticals Priced An Underwritten Offering Of 4.76M Shares (Or Pre-funded Warrants In Lieu Thereof) And Investor Warrants To Purchase Up To 4.76M Shares, Combined Price Of Each Share And Accompanying Warrant Is $1.05 And Each Pre-funded...
reviva pharmaceuticals定價了一項476萬股的包銷發行（或以預融資認股權代替）和投資者認股權，以購買多達476萬股，每股及附帶認股權的組合價格爲1.05美元，每份預融資...
Reviva Pharmaceuticals Priced An Underwritten Offering Of 4.76M Shares (Or Pre-funded Warrants In Lieu Thereof) And Investor Warrants To Purchase Up To 4.76M Shares, Combined Price Of Each Share And Accompanying Warrant Is $1.05 And Each Pre-funded Warrant And Accompanying Warrant Is $1.0499
reviva pharmaceuticals定價了一項476萬股的承銷發行（或預先擔保的認股權證），以及投資者認股權證，以購買多達476萬股，每股及相應認股權證的組合價格爲1.05美元，每個預先擔保的認股權證及相應認股權證的價格爲1.0499美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。